Year archive

China Medical System Holdings Limited — 2021 filings

All 65 regulatory filings released by China Medical System Holdings Limited (867) in 2021, sourced directly from the official regulator.

65 Filings

2021 Period

2021 filings (65)

Filing	Released	Lang
Voluntary and Business Update Announcement Achieving Collaboration with OVMEDI for the Embedding Thread Product Capital/Financing Update	2021-12-14	English
Voluntary and Business Update Announcement New Drug Application of Methotrexate Injection, Pre-filled Syringe Accepted in China Regulatory Filings	2021-12-09	English
Voluntary and Business Update Announcement Acquisition of a Medical Aesthetic Specialty Company Capital/Financing Update	2021-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Transaction in Own Shares	2021-12-01	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-30	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-18	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-17	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-15	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-12	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-10	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-09	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-08	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-05	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-04	English
Next Day Disclosure Return Transaction in Own Shares	2021-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Regulatory Filings	2021-11-03	English
Next Day Disclosure Return Transaction in Own Shares	2021-10-22	English
Voluntary and Business Update Announcement New Drug Application of Tildrakizumab Accepted in China Regulatory Filings	2021-10-14	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2021-10-06	English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGES IN THE COMPOSITION OF BOARD COMMITTEES Board/Management Information	2021-10-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 Regulatory Filings	2021-10-06	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-27	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-20	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-16	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-15	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-13	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-08	English
Interim Report 2021 Interim / Quarterly Report H1 2021	2021-09-07	English
Notification Letter Report Publication Announcement	2021-09-07	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Regulatory Filings	2021-09-06	English
Next Day Disclosure Return Transaction in Own Shares	2021-09-02	English
Next Day Disclosure Return Transaction in Own Shares	2021-08-31	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2021-08-30	English
Next Day Disclosure Return Transaction in Own Shares	2021-08-30	English
Next Day Disclosure Return Transaction in Own Shares	2021-08-27	English
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2021 Notice of Dividend Amount	2021-08-23	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021 Interim / Quarterly Report H1 2021	2021-08-23	English
Voluntary and Business Update Announcement Methotrexate Injection, Pre-filled Syringe Granted an Approval for Drug Clinical Trial Regulatory Filings	2021-08-13	English
Notice of Board Meeting Regulatory Filings	2021-08-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 Regulatory Filings	2021-08-05	English
Voluntary and Business Update Announcement Methylthioninium Chloride Enteric-coated Sustained-release Tablets Granted an Approval for Drug Clinical Trial Regulatory Filings	2021-08-02	English
Voluntary and Business Update Announcement Positive Results for Tildrakizumab Phase III Clinical Trial in China Regulatory Filings	2021-07-21	English
Voluntary and Business Update Announcement New Drug Application of Diazepam Nasal Spray Accepted in China Regulatory Filings	2021-07-05	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2021-07-02	English
VOLUNTARY JOINT ANNOUNCEMENT STRATEGIC COLLABORATION MEMORANDUM Regulatory Filings	2021-06-10	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2021-06-02	English
Voluntary and Business Update Announcement Acquisition of a Medical Aesthetic Focused Ultrasound Technology Platform Company Capital/Financing Update	2021-05-17	English
Monthly Return of Equity Issuer on Movements in Securities Capital/Financing Update	2021-05-06	English
ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 APRIL 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-27	English
Voluntary and Business Update Announcement Equity investment in and Establishment of a Joint Venture with Trinomab Capital/Financing Update	2021-04-18	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2021-04-01	English
NOTIFICATION LETTER Report Publication Announcement	2021-04-01	English
Annual Report 2020 Annual Report FY 2020	2021-04-01	English
NOTIFICATION LETTER Report Publication Announcement	2021-03-24	English
FORM OF PROXY AGM Information	2021-03-24	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-03-24	English
PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND, GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2021-03-24	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020 Annual Report FY 2020	2021-03-16	English
Notice of Board Meeting Regulatory Filings	2021-03-04	English
Monthly Return of Equity Issuer on Movements in Securities Capital/Financing Update	2021-03-02	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2021-02-03	English
Voluntary and Business Update Announcement Acquisition of a Dermatology Specialty Company Luqa Ventures Co., Limited Capital/Financing Update	2021-02-01	English
Voluntary and Business Update Announcement Desidustat Tablets Being Granted an Approval for Drug Clinical Trial Regulatory Filings	2021-01-19	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2021-01-05	English

Filings by year

2026 52 filings
2025 78 filings
2024 55 filings
2023 42 filings
2022 47 filings
2021 65 filings
2020 47 filings
2019 36 filings
2018 55 filings
2017 41 filings
2016 40 filings
2015 39 filings
2014 47 filings
2013 31 filings
2012 35 filings
2011 45 filings
2010 10 filings